procedures would be done by OPCAB; yet, in today's clinical practice, OPCAB has not reached this level of use.A recent consensus document based on a metaanalysis of published studies recommends that OPCAB should be considered in both low-risk and high-risk patients to reduce perioperative mortality, morbidity, and resource utilization beyond that achieved with CPB surgery.1 This analysis suggested that OPCAB potentially decreases perioperative myocardial infarction and other myocardial injury, stroke, atrial fibrillation, renal damage, and injury to the brain. Another study reported that OPCAB patients have decreased atrial fibrillation, transfusion and inotrope requirements, respiratory infections, ventilation time, ICU stay, and hospital stay. However, several meta-analyses showed that there is no difference (advantage) in short-term or long-term mortality and morbidity between OPCAB and on-pump cardiopulmonary bypass-coronary artery bypass grafting (CPB-CABG) as shown in observational studies.1,3,4 Moreover, they stated that C oronary artery bypass grafting (CABG) surgery using cardiopulmonary bypass (CPB) can be associated with neurological, renal, and pulmonary morbidity, as well as with inflammatory and hemostatic complications. Coronary artery bypass grafting without the use of CPB, off-pump coronary artery bypass (OPCAB) surgery, became increasingly popular in the early 1990s with the development of new techniques for coronary exposure and stabilization of the myocardium. The main advantages of OPCAB surgery over the CPB technique include less traumatic surgical intervention, shortened hospital or intensive care unit (ICU) stay, and reduced patient recovery time. It was expected that more than 50% of all coronary revascularization To characterize hemostatic differences imposed by 2 common cardiac surgeries, the authors studied patients undergoing coronary artery revascularization by offpump (n = 13) or cardiopulmonary bypass on-pump (n = 26) technique. Blood samples collected to 4 days postsurgery were evaluated by flow cytometry and enzymelinked immunosorbent assay. A significant inflammatory response occurred in both the groups after surgery shown by increased interleukin cytokines and C-reactive protein; however, levels peaked lower and hours later in the off-pump group. Platelets (P-selectin; platelet-leukocyte complexes) and leukocytes (CD11b) were activated only in on-pump patients. Thrombin generation was enhanced in both groups after surgery. Only in the on-pump patients, the thrombin-antithrombin complex, prothrombin fragment 1.2, and thrombomodulin (vascular integrity) decreased intraoperatively. Tissue plasminogen activator and plasminogen activator inhibitor-1 were greater in the on-pump patients. Off-pump surgery may place patients at higher risk of postoperative hypercoagulability because of normal platelet function, intraoperative thrombin generation, less fibrinolytic activity, and lack of vascular protection.